Hospital cost drivers: An evaluation of 1998-2001 state-level data

American Journal of Managed Care

Volumn 9, Issue SPEC. ISS. 1, 2003, Pages

  Hay, Joel W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETANERCEPT; GLATIRAMER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INTERFERON BETA SERINE;

ARTHRITIS; ARTICLE; BIOTECHNOLOGY; CARDIOVASCULAR DISEASE; DRUG COST; GOVERNMENT; HEALTH CARE; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH INSURANCE; HOSPITAL COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCOME; MANAGED CARE; MARKETING; MULTIPLE SCLEROSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NURSE; ORGAN TRANSPLANTATION; OUTPATIENT DEPARTMENT; PHYSICIAN; POPULATION; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UNITED STATES;

COST OF ILLNESS; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HOSPITAL COSTS; INSURANCE COVERAGE; LENGTH OF STAY; MULTIVARIATE ANALYSIS; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 0038127272     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Goetghebeur MM, Forrest S, Hay JW. Understanding the underlying drivers of inpatient cost growth: A literature review. Am J Manag Care. 2003;9:SP3-SP12
2. Hay J, Yu W. Drug patents and prices, can we achieve better outcomes? In: Triplett J, ed. Measuring the Prices of Medical Treatments. Washington, DC: Brookings Press; 1999:152-195.
3. Martin A, Whittle L, Levit K, Won G, Hinman L. Health care spending during 1991-1998: A fifty-state review. Health Aff (Millwood). 2002;21(4):112-126.
4. Johnston J. Econometric Methods. 2nd ed. New York: McGraw-Hill, 1972.
5. Dawson-Saunders B, Trapp R. Basic and Clinical Biostatistics. Norwalk, Conn: Appleton and Lange; 1990.
6. Hanushek E, Jackson J. Statistical Methods for Social Scientists. New York: Academic Press; 1977.
7. Census Bureau, US Department of Commerce. Table 3: Female population by age, race and Hispanic or Latino origin for the United States: 2000. Available at: http://www.census.gov/population/cen2000/phc-t9/tab03.xls. Accessed September 9, 2002.
8. Yett D, Der W, Ernst R, Hay J. A model of physician pricing, output, and health insurance reimbursement: Findings from study of two Blue Shield plans' claims data. In: Van der Gaag J, Neenan W, Tsukahara T, eds. Essays in Health Economics. New York: Praeger Press; 1982:197-230.
9. Reinhardt U, Hussey P, Anderson G. Cross-national comparisons of health systems using OECD data, 1999. Health Aff (Millwood). 2002;21(3):169-181.
10. National Center for Health Workforce Analysis. Projected Supply, Demand, and Shortages of Registered Nurses: 2000-2020. Hyattsville, Md: US Department of Health and Human Services, Health Resources and Services Administration Bureau of Health Professions; July 2002.
11. Hay J. Variation in per capita pharmaceutical expenditures: Are drugs complements or substitutes? In: Lindgren B, ed. Pharmaceutical Economics. Malmo, Sweden: Liber Forlag Press; 1985:21-36.
12. Wooldridge J. Econometric Analysis of Cross Section and Panel Data. Cambridge, Mass: MIT Press; 2002.
13. Lewin Group. October 23, 2002. Available at: Available at: http://bcbshealthissues.com/costpressconf/materials.vtml. Accessed May 23, 2003.